299 related articles for article (PubMed ID: 26680172)
21. CRISPR genome-editing: A medical revolution.
Butler JR; Tector AJ
J Thorac Cardiovasc Surg; 2017 Feb; 153(2):488-491. PubMed ID: 28104200
[No Abstract] [Full Text] [Related]
22. The New State of the Art: Cas9 for Gene Activation and Repression.
La Russa MF; Qi LS
Mol Cell Biol; 2015 Nov; 35(22):3800-9. PubMed ID: 26370509
[TBL] [Abstract][Full Text] [Related]
23. Bioethics. Embryo engineering alarm.
Vogel G
Science; 2015 Mar; 347(6228):1301. PubMed ID: 25792311
[No Abstract] [Full Text] [Related]
24. Genome editing using Cas9 nickases.
Trevino AE; Zhang F
Methods Enzymol; 2014; 546():161-74. PubMed ID: 25398340
[TBL] [Abstract][Full Text] [Related]
25. Editorial: CRISPR in Nucleic Acids Research.
Stoddard BL; Fox K
Nucleic Acids Res; 2016 Jun; 44(11):4989-90. PubMed ID: 27325109
[No Abstract] [Full Text] [Related]
26. Genome editing using artificial site-specific nucleases in zebrafish.
Hisano Y; Ota S; Kawahara A
Dev Growth Differ; 2014 Jan; 56(1):26-33. PubMed ID: 24117409
[TBL] [Abstract][Full Text] [Related]
27. Generating genetically modified mice using CRISPR/Cas-mediated genome engineering.
Yang H; Wang H; Jaenisch R
Nat Protoc; 2014 Aug; 9(8):1956-68. PubMed ID: 25058643
[TBL] [Abstract][Full Text] [Related]
28. RNA-dependent DNA endonuclease Cas9 of the CRISPR system: Holy Grail of genome editing?
Gasiunas G; Siksnys V
Trends Microbiol; 2013 Nov; 21(11):562-7. PubMed ID: 24095303
[TBL] [Abstract][Full Text] [Related]
29. [Not Available].
Nau JY
Rev Med Suisse; 2016 Mar; 12(512):666-7. PubMed ID: 27172698
[No Abstract] [Full Text] [Related]
30. Engineering the Caenorhabditis elegans genome with CRISPR/Cas9.
Waaijers S; Boxem M
Methods; 2014 Aug; 68(3):381-8. PubMed ID: 24685391
[TBL] [Abstract][Full Text] [Related]
31. [Not Available].
Nau JY
Rev Med Suisse; 2016 Apr; 12(514):766-7. PubMed ID: 27263157
[No Abstract] [Full Text] [Related]
32. CRISPR craze conquers the RNA world: precise manipulation of DNA and RNA based on a bacterial defense system.
Rentmeister A
Angew Chem Int Ed Engl; 2015 Apr; 54(16):4710-2. PubMed ID: 25727398
[No Abstract] [Full Text] [Related]
33. Genomic editing opens new avenues for zebrafish as a model for neurodegeneration.
Schmid B; Haass C
J Neurochem; 2013 Nov; 127(4):461-70. PubMed ID: 24117801
[TBL] [Abstract][Full Text] [Related]
34. [Progress of genome engineering technology via clustered regularly interspaced short palindromic repeats--a review].
Li H; Qiu S; Song H
Wei Sheng Wu Xue Bao; 2013 Oct; 53(10):1025-30. PubMed ID: 24409757
[TBL] [Abstract][Full Text] [Related]
35. Genetically-modified insects to combat vector-borne diseases — curtain rise or fall?
Nat Rev Genet; 2016 Mar; 17(3):123. PubMed ID: 27314131
[No Abstract] [Full Text] [Related]
36. [The revolution of the CRISPR is underway].
Gilgenkrantz H
Med Sci (Paris); 2014 Dec; 30(12):1066-9. PubMed ID: 25537031
[No Abstract] [Full Text] [Related]
37. Dual sgRNAs facilitate CRISPR/Cas9-mediated mouse genome targeting.
Zhou J; Wang J; Shen B; Chen L; Su Y; Yang J; Zhang W; Tian X; Huang X
FEBS J; 2014 Apr; 281(7):1717-25. PubMed ID: 24494965
[TBL] [Abstract][Full Text] [Related]
38. RNA events. Cas9 targeting and the CRISPR revolution.
Barrangou R
Science; 2014 May; 344(6185):707-8. PubMed ID: 24833384
[No Abstract] [Full Text] [Related]
39. GONAD: Genome-editing via Oviductal Nucleic Acids Delivery system: a novel microinjection independent genome engineering method in mice.
Takahashi G; Gurumurthy CB; Wada K; Miura H; Sato M; Ohtsuka M
Sci Rep; 2015 Jun; 5():11406. PubMed ID: 26096991
[TBL] [Abstract][Full Text] [Related]
40. Nuclease-mediated genome editing: At the front-line of functional genomics technology.
Sakuma T; Woltjen K
Dev Growth Differ; 2014 Jan; 56(1):2-13. PubMed ID: 24387662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
